KSAT San AntonioStem cell therapy for osteoarthritisKSAT San AntonioIt is currently an incurable disease in which the joints deteriorate. Now, a therapy that has been used in eye surgery and to heal the skin of burn victims is being used for the first … Continue reading
Gizmodo |
Here’s Why Today’s Decision On Who Invented CRISPR Matters
Gizmodo Since CRISPR-Cas9’s discovery, researchers have discovered many alternatives to it that may wind up being superior. For instance in 2015, the Broad Institute announced a second CRISPR system, CRISPR–Cpf1 and last May, Chinese researchers … Why the CRISPR patent verdict isn’t the end of the story 6 Takeaways from the CRISPR Patent Decision Berkeley statement regarding patent board’s decision on CRISPR-Cas9 gene-editing technology | Berkeley News |
Forbes |
Stop Freaking Out About CRISPR! (Except For One Thing)
Forbes It’s been a huge two days for CRISPR, the biotechnology innovation that makes it far easier for scientists to edit DNA in living cells. Yesterday, a report from the National Academies of Science didn’t rule out eventually using the technology to … Broad Institute scientist prevails in epic patent fight over CRISPRWashington Post CRISPR patents, potentially worth billions, belong to Broad InstituteThe Verge Patent Office Hands Win in CRISPR Battle to Broad InstituteMIT Technology Review TIME –Genetic Engineering & Biotechnology News –Science Magazine –UC Berkeley News – University of California, Berkeley all 29 news articles » |
|
CRISPR (CRSP), Intellia (NTLA), Caribou, ERS Genomics Provide Update on CRISPR/Cas9 US Patent Interference …
StreetInsider.com The USPTO has rejected a series of patent applications filed by Broad that are directed to uses of CRISPR/Cas9 Technology in eukaryotic cells (as in the claims involved in the interference) as being “non-novel” in view of the UC’s prior-filed patent … The Intellia Therapeutics Inc (NTLA) Stock Rating Decreased by the Zacks Investment ResearchDailyQuint |